Oncology - Pharma Deals News, page-218

Well it's annoying, but I take it as a sign that something is afoot since several disingenuous trolls have come out of the woodwork at the same time, all with the apparent intent to wreak havoc and mock shareholders. Personally, I welcome honest criticism if it shines a light on aspects I've missed and should take into consideration. But it's completely pointless if a post is vague to the point that it could be dropped into any discussion about any ticker and be equally as relevant. Wonder what reason there'd be to try to sow fear and uncertainty..

It's okay, though. Shareholders can take solace in the fact that no real arguments have been presented, and the fundamentals remain the same as they were before the trolls.

We have a promising drug, an active base of truly invested shareholders, and a solid management team to take things to the next level!